Most of the patients undergoing mastectomy opt for breast reconstruction, with an increasing trend making it difficult to extrapolate these results to the reconstructed population.[ 16 ] None of the major trials reported on acute toxicity; however, in the MDACC trial, overall acute grade two and three effects were significantly reduced with HF-WBI as compared to CF-WBI, and several patient-repor
← all excerpts
Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer.
1
—
—